BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 38442594)

  • 1. Acute myeloid leukemia due to germline CEBPA mutation in a Syrian family.
    Wafa A; Ali B; Moassass F; Kheder M; Aljapawe A; Al-Halabi B; Mrasek K; Liehr T; Al-Achkar W
    Mol Genet Genomic Med; 2022 Feb; 10(2):e1854. PubMed ID: 35032366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
    Pabst T; Eyholzer M; Haefliger S; Schardt J; Mueller BU
    J Clin Oncol; 2008 Nov; 26(31):5088-93. PubMed ID: 18768433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease evolution and outcomes in familial AML with germline CEBPA mutations.
    Tawana K; Wang J; Renneville A; Bödör C; Hills R; Loveday C; Savic A; Van Delft FW; Treleaven J; Georgiades P; Uglow E; Asou N; Uike N; Debeljak M; Jazbec J; Ancliff P; Gale R; Thomas X; Mialou V; Döhner K; Bullinger L; Mueller B; Pabst T; Stelljes M; Schlegelberger B; Wozniak E; Iqbal S; Okosun J; Araf S; Frank AK; Lauridsen FB; Porse B; Nerlov C; Owen C; Dokal I; Gribben J; Smith M; Preudhomme C; Chelala C; Cavenagh J; Fitzgibbon J
    Blood; 2015 Sep; 126(10):1214-23. PubMed ID: 26162409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and management of germline CEBPA-mutated carriers.
    Pan L; Li Y; Gao H; Lai X; Cai Y; Chen Z; Li X; Wang SY
    Leuk Res; 2024 Mar; 138():107453. PubMed ID: 38442594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial CEBPA-mutated acute myeloid leukemia.
    Tawana K; Rio-Machin A; Preudhomme C; Fitzgibbon J
    Semin Hematol; 2017 Apr; 54(2):87-93. PubMed ID: 28637622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations.
    Yuan J; He R; Alkhateeb HB
    Curr Hematol Malig Rep; 2023 Oct; 18(5):121-129. PubMed ID: 37261703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory evaluation and prognostication among adults and children with CEBPA-mutant acute myeloid leukemia.
    Mendoza H; Podoltsev NA; Siddon AJ
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():86-95. PubMed ID: 34288448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary acute myeloid leukemia associated with C-terminal CEBPA germline variants.
    Harrigan AM; Trottier AM
    Fam Cancer; 2023 Jul; 22(3):331-339. PubMed ID: 36879149
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.